Pharma Parenteral Packaging Market Size, Share & Trends Analysis Report By Product Type (Bottles, Ampoules, Vials, Prefilled Syringes, Cartridges, Others), By Application (Small Volume Parenteral, Large Volume Parenteral), By Region, And By Segment Forecasts, 2024-2032

Major Key Players in the Pharma Parenteral Packaging Market:

1. Adelphi Healthcare Packaging
2. Akorn, Inc.
3. Alcami Corporation, Inc.
4. Ardena Holding NV
5. Baxter International Inc.
6. Becton, Dickinson and Company
7. Berkshire Sterile Manufacturing
8. Berry Global Inc.
9. Catalent Inc.
10. Gerresheimer AG
11. Nipro Corporation
12. PCI Pharma Services
13. Schott AG
14. SGD Pharma
15. SiO2 Materials Science
16. Stevanato Group S.p.A
17. Terumo Corporation
18. UDG Healthcare Plc.
19. West Pharmaceutical Services, Inc.
20. Ypsomed Holding AG

Recent Developments

• January 2024: SCHOTT Pharma expanded its global manufacturing network by investing a double-digit million euros in a new production site for pharma drug containment solutions and delivery systems in Jagodina, central Serbia.

• October 2023: Gerresheimer launched COP (Cyclic Olefin Polymer) to fill and store sensitive biopharmaceutical mRNA active ingredients.

• 2023: B.D. introduced the all-in-one prefilled flush syringe with an integrated disinfection unit.

Market Segmentation

By Drug Type

• Small Molecules
• Biologics
• Vaccines
• Biosimilars
• Others

By Product Type

• Bottles
• Ampoules
• Vials
• Prefilled Syringes
• Cartridges
• Others

By Material:

• Glass
• Polymer
• PVC
• Others

By Application Type:

• Small Volume Parenteral
• Large Volume Parenteral

By Region

• North America
  • The US
  • Canada
  • Mexico
• Europe
  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific:
  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America
• Middle East & Africa
  • GCC Countries
  • South Africa
  • Rest of the Middle East and Africa

Key Market Insights

Prefilled Syringes Segment

The prefilled syringes segment is anticipated to be a major contributor to the pharma parenteral packaging market. The segment’s growth is driven by the ease of use of prefilled syringes, their preference for small molecules over other dosage forms, lower dosage errors, and the rising demand for prefilled insulin syringes due to the increasing incidence of diabetes.

Glass Material Segment

The glass segment is expected to witness rapid growth, primarily due to glass’s impermeable and non-porous nature, which helps retain product composition. Glass also protects items from ultraviolet radiation, ensuring longer freshness, particularly in countries like the US, Germany, the UK, China, and India.

Regional Insights

North America

North America holds a significant revenue share in the pharma parenteral packaging market. This is attributed to the presence of prominent parenteral packaging companies, the increasing demand for injectable medication packaging, and the overall growth of the pharmaceutical industry in the region.

Asia-Pacific

The Asia-Pacific region is projected to grow at the highest rate during the study period. The growth is driven by the increasing incidence of chronic and infectious diseases, the rising need for pharmaceutical vial packaging, and the expansion of vaccination programs.

Conclusion

The Pharma Parenteral Packaging Market is poised for significant growth driven by the increasing demand for safe and sterile pharmaceutical packaging solutions. Despite challenges such as stringent regulations and high raw material costs, advancements in packaging technologies and the growing adoption of biologics and injectable drugs are expected to support market expansion. The competitive landscape features key players continuously innovating to meet evolving market needs, ensuring the safe and effective delivery of pharmaceutical products.